The
inflammation process is a coordinated response of the organism related to immune response with release of pro-inflammatory substances, as
nitric oxide, TNF-α and IL-1β. In this work, a series of lipophilic
amino alcohols were evaluated on RAW264.7 and primary macrophages for the modulation of
nitric oxide and TNF-α. The most potent compounds were submitted to the treatment of BALB/c mice and evaluation of the
carrageenan-induced paw
edema and TNF-α and IL1-β release in the paws and anti-OVA delayed type
hypersensitivity reaction. RAW264.7 and primary macrophages were incubated in the presence of
amino alcohols at different concentrations (1, 0.5, 0.05 and 0.005 μg mL(-1)). All tested compounds were not cytotoxic, however the inhibition of NO and TNF-α were observed only in RAW264.7 cultures. The NO production were reduced in 100% for all compounds, but only the compounds 4a and 4b expressively reduced the TNF-α release (67% and 92% respectively). On the
carrageenan-induced paw
edema, the compound 4b treatment showed reduction of
edema, TNF-α and IL-1β as efficient as
dexamethasone treatment. Meanwhile, the compound 4a treatment showed only slight reduction of paw
edema. In the anti-OVA DTH reaction, both compounds showed reduction in the paw
edema as effective as
dexamethasone. In function of the observed results in vitro and in the acute and anti-OVA
inflammation of mice paw
edema compound 4b showed promissory anti-inflammatory properties.